Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Influenza

  Free Subscription


08.07.2019

3 J Infect Dis
1 J Virol
1 J Virol Methods
1 Lancet Infect Dis
1 MMWR Morb Mortal Wkly Rep
1 PLoS One
4 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    J Infect Dis

  1. LARTEY S, Zhou F, Brokstad KA, Mohn KG, et al
    Live attenuated influenza vaccine induces tonsillar follicular T helper cell responses that correlate with antibody induction.
    J Infect Dis. 2019 Jun 27. pii: 5524503. doi: 10.1093.
    PubMed     Text format     Abstract available

  2. BUCHHOLZ UJ, Cunningham CK, Muresan P, Gnanashanmugam D, et al
    Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children.
    J Infect Dis. 2018 Mar 2. pii: 4917539. doi: 10.1093.
    PubMed     Text format     Abstract available

  3. MCFARLAND EJ, Karron RA, Muresan P, Cunningham CK, et al
    Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children.
    J Infect Dis. 2018 Mar 2. pii: 4917538. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Virol

  4. LI X, Gao Y, Ye Z
    A Single Amino Acid Substitution at Residue 218 of Hemagglutinin Improves the Growth of Influenza A(H7N9) Candidate Vaccine Viruses.
    J Virol. 2019 Jul 3. pii: JVI.00570-19. doi: 10.1128/JVI.00570.
    PubMed     Text format     Abstract available


    J Virol Methods

  5. TAYLOR AW, Dawson ED, Blair RH, Johnson JE Jr, et al
    Analytical Evaluation of the Microarray-Based FluChip-8G Influenza A+B Assay.
    J Virol Methods. 2019 Jul 1:113686. doi: 10.1016/j.jviromet.2019.113686.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  6. MAZUR NI, Higgins D, Nunes MC, Melero JA, et al
    The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates.
    Lancet Infect Dis. 2018 Jun 15. pii: S1473-3099(18)30292.
    PubMed     Text format     Abstract available


    MMWR Morb Mortal Wkly Rep

  7. GROENEWOLD MR, Burrer SL, Ahmed F, Uzicanin A, et al
    Health-Related Workplace Absenteeism Among Full-Time Workers - United States, 2017-18 Influenza Season.
    MMWR Morb Mortal Wkly Rep. 2019;68:577-582.
    PubMed     Text format     Abstract available


    PLoS One

  8. WU HH, Chang YY, Kuo SC, Chen YT, et al
    Influenza vaccination and secondary prevention of cardiovascular disease among Taiwanese elders-A propensity score-matched follow-up study.
    PLoS One. 2019;14:e0219172.
    PubMed     Text format     Abstract available


    Vaccine

  9. CORONEL J, Behrendt I, Burgin T, Anderlei T, et al
    Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems.
    Vaccine. 2019 Jun 29. pii: S0264-410X(19)30764.
    PubMed     Text format     Abstract available

  10. VAN AALST R, Russo EM, Neupane N, Mahmud SM, et al
    Economic assessment of a high-dose versus a standard-dose influenza vaccine in the US Veteran population: Estimating the impact on hospitalization cost for cardio-respiratory disease.
    Vaccine. 2019 Jun 28. pii: S0264-410X(19)30843.
    PubMed     Text format     Abstract available

  11. HAUSER MI, Muscatello DJ, Soh ACY, Dwyer DE, et al
    An indirect comparison meta-analysis of AS03 and MF59 adjuvants in pandemic influenza A(H1N1)pdm09 vaccines.
    Vaccine. 2019 Jun 25. pii: S0264-410X(19)30801.
    PubMed     Text format     Abstract available

  12. DE OLIVEIRA BERNARDO C, Gonzalez-Chica DA, Chilver M, Stocks N, et al
    Influenza immunisation coverage from 2015 to 2017: A national study of adult patients from Australian general practice.
    Vaccine. 2019 Jun 25. pii: S0264-410X(19)30819.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: